Certain breast cancer types, like luminal cancer and those in dense breasts, are more likely to be missed by AI in mammography screening.
Key Details
- 1South Korean researchers reviewed breast images from nearly 1,100 women screened between 2014 and 2020.
- 2AI tools were found to miss cancers with features such as luminal subtype, dense breast tissue, and lesions outside the mammary zone.
- 3The study was published in RSNA's journal Radiology.
- 4Experts urge careful assessment of cases at higher risk of AI error.
Why It Matters
Understanding which cancers AI is most likely to miss can help optimize AI integration into breast imaging workflows, ensuring that radiologists remain vigilant in specific high-risk contexts. This research offers guidance to improve both detection and patient outcomes.
Source
Radiology Business
Related News
•AuntMinnie
Deep Learning Model Predicts Brain Tumor MRI Enhancement Without Gadolinium
German researchers developed a deep learning approach to predict MRI contrast enhancement in brain tumors without the need for gadolinium-based agents.
•Radiology Business
Study Highlights Limitations of AI in Prostate MRI Screening
New research points to several shortcomings in implementing AI for MRI-based prostate cancer screening.
•Radiology Business
SimonMed Imaging Introduces Paid AI Add-Ons for Routine Exams
SimonMed Imaging is launching new AI-powered elective services for routine imaging exams with additional out-of-pocket costs for patients.